Extensive use of monoamine oxidase inhibitors and imipramine in psychiatric practice has revealed serious toxic reactions. It has been observed that combination of monoamine oxidase inhibitor and imipramine produces a symptom complex characterized by hyperexcitement, motor restlessness and hyperpyrexia (1-6). Furthermore, hypertensive crisis, subarachnoid haemorrhage and pulmonary oedema has been reported to occur in patients who were maintained on monoamine oxidase inhibitor and took cheese or broad beans (7 , 8). High contents of tyramine in cheese and 3-4 dihydroxyphenylalanine (dopa) in broad beans have been sug gested to be responsible for the above mentioned serious side effects. Since it is known that in MAO inhibitor pretreated animals administration of both, tyramine and dopa increase circulating catecholamine content
of the body, it seems likely that catecholamines might be playing a key role in the causation of these side effects.
Loveless and Maxwell (9) have studied MAO inhibitor-imipramine induced fatal hyperpyrexia but they could not come to any definite conclusion regarding its mechanism. As all above observations suggest a possible role of catecholamines in these side effects, it was thought worthwhile to investigate the role of catecholamines by studying the effect of specific a and ~-adrenergic blockers on the fatal hyperpyrexia induced by MAO inhibitor-imipramine combination.
The present study was carried out on thirty-five adult albino rabbits of either sex. The animals were pretreated with niamid (100 mg/kg i.p.) for two days. On the following days the rabbits were placed in stocks for recording the rectal temperatures.
Control recordings of the temperature were taken for one hour before the administration of imipramine (the incompatible agent). Imipramine was infused into a marginal ear vein at a rate of 2.5 mg/kg/min. Rectal temperatures were recorded at 30 minute intervals for one and a half hour. Two groups of controls were used in this study. In the first control group instead of imipramine only intravenous saline infusion was given. In the second control group intravenous infusion of imipramine was given in untreated animals. Either the rise of rectal temperature to more than 3°C or the occurrence of mortality during the period of observations was taken as the criterion of fatal hyperpyrexia. The results of the present study are shown in Table 1 . It was observed that the control groups (which received either only niamid or imipramine with saline) did not exhibit fatal hyperpyrexia. The group which received niamid (100 mg/kg i.p.) for two days and then imipramine (2.5 mg/kg i.v.) showed hyperpyrexia in three out of six animals. The other group which received niamid (100 mg/kg i.p.) for two days and a higher dose of imipramine (5.0 mg/kg i.v.) exhibited fatal hyperpyrexia in 100% animals. Two out of six rabbits died during the study.
Pretreatment with dibenzyline (10.0 mg/kg i.p.) half hour before imipramine infusion completely prevents the development of the fatal hyperpyrexial response and also the mortality is reduced.
Prior n-receptor blockade by propranolol (5.0 mg/kg i.p.) markedly enhances the toxicity, as all the six animals showed hyperpyrexia and expired during the study. INPEA, another /3-receptor blocking agent did not significantly alter the development of fatal hyperpyrexial response.
The results of the present study clearly show that a combination of niamid (a MAO inhibitor) with imi pramine produces fatal hyperpyrexia.
Blockade of hyperpyrexia by a-receptor blocking agent, dibenzyline, suggests the role of catecholamines and involvement of a-adrenergic receptors in this response . However, further study is required to prove this contention.
Alpha receptor blocking agents may prove life saving for the cases of fatal hyperpyrexia due to MAO inhibitor-imipramine combination .
Since out of two a-receptor blocking agent only propranolol enhanced the toxicity , such a potentiation does not seem to be related to the n-receptor blockade. It is more likely that prepranolol does so by virtue of its catecholamine releasing action.
